| Home page | Contact us | Selected articles | A-Z Index of topics | Newsgroup |
| Subscribe | Order back issues | Article extracts | Back issue contents | Autism books |
Nineteen children with autism and eight with Asperger's syndrome, aged two to eight years, were treated with cerebrolysin in an in-patient clinic. All the patients received 10 daily micro-injections (intramuscularly and perinervously) of 0.1 ml for five days.
The research team, led by Dr M.G. Krasnoperova, found the therapy resulted in improvement of cognitive functions (expressive and receptive speech, fine motor and play skills). Positive effects were revealed in all the patients with Asperger's syndrome and in 89 per cent of the patients with autism, the researchers reported.
Improvement in cognitive function development appeared to be more pronounced in the patients with Asperger's syndrome, the scientists wrote. They noted that none of the patients had suffered any side-effects to the drug.
| Search this site
|
|
| BACK ISSUE CONTENTS AND FRONT COVERS | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VOLUME 1, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | VOLUME 2, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| VOLUME 3, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | VOLUME 4, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||||
| Home page | Contact us | Selected articles | A-Z Index of topics | Newsgroup |
| Subscribe | Order back issues | Article extracts | Back issue contents | Autism books |